VIVUS Inc. (VVUS)
Loading...
Symbols:
VVUS Forum Topics
- All Comments on VVUS
- General Discussion on VVUS
- Biotech Day In Review: Novartis Pulls Zelnorm Off The Market [view article]
- Erectile Dysfunction Market Shows Flaccid Growth, But VIVUS May Rise High (PFE, LLY, GSK, VVUS, NEXM) [view article]
- VIVUS' Strong Pipeline For Sexual Disfunction Treatments (VVUS) [view article]
loading ...Recent VVUS Articles
- Analyst Notes: Lilly Gets A Lift, Pfizer Goes Pfft
- VIVUS, Inc. Stands To Gain From Weight Loss
- Biotech Day In Review: Novartis Pulls Zelnorm Off The Market
- VIVUS Looking to Profit from Obesity and Sexual Dysfunction
- Vivus Inc: Tempting, But Beware (VVUS)
- VIVUS' Strong Pipeline For Sexual Disfunction Treatments (VVUS)
- Erectile Dysfunction Market Shows Flaccid Growth, But VIVUS May Rise High (PFE, LLY, GSK, VVUS, NEXM)
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Editors
General Discussion on VVUS
Is this a buy or a sell? ReplyBiotech Day In Review: Novartis Pulls Zelnorm Off The Market [view article]
Astellas is quite right : REGN has fantastic monoclonal technology. Rather than manipulate the Fc fragment, they know how to manipulate the moieties of the receptors linked to it. This is unique.Have a look at a picture that hopefully makes this a bit more simple to understand :
www.healthvalue.net/VE... Reply